Urgent Care Center at Renaissance Offers Fast Care for Patients in the RGV

Translate to Spanish or other 102 languages!

 Mega Doctor News

- Advertisement -

Located in close proximity to the Emergency Room at Doctors Hospital at Renaissance, the Urgent Care Center at Renaissance treats all non-life-threatening injuries and illnesses

Edinburg, TX—At Doctors Hospital at Renaissance, we aim to deliver quality care in a timely and efficient manner. To facilitate time-sensitive patient needs, we established the Urgent Care Center at Renaissance. Our highly skilled physicians, nurses, and specialists provide the expert care patients need in a timely, cost effective, and convenient environment.

Urgent Care Center at Renaissance patients are seen and treated by either a physician or nurse practitioner promptly; no appointment is necessary. With convenient hours to treat the most unlikely of injuries and illnesses, the Urgent Care Center at Renaissance is open seven days a week—Monday through Friday from 4:30 PM until 2:30 AM and Saturday and Sunday from 12:00 PM until 12:00 AM.

- Advertisement -

Services provided at the Urgent Care Center at Renaissance include:

‒     Acute illness treatment – cough, cold, sore throat, flu-like symptoms

‒     Minor burns

‒     Sprains and strains, broken bones

- Advertisement -

‒     Cuts and lacerations

‒     Non-life-threatening allergic reactions

‒     Rash/ skin irritations

‒     Ear infections

‒     Diagnostic testing and x-ray imaging

‒     Physical Exams

‒     Lab services

Our mission is to decrease waiting times in the emergency room by offering an alternative means of care for lower-acuity patients, while maintaining the Doctors Hospital at Renaissance standard of care. All insurance plans are accepted, and patients are located close to the Doctors Hospital at Renaissance emergency room should the need for more emergent care arise.

To get more information about the Urgent Care Center at Renaissance, please call 956-362-5050 or visit the Doctors Hospital at Renaissance website at www.dhr-rgv.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -